For Glutathione research procurement, both categories matter
Kittana et al., 2023)
NAD is the collective term for the many different phases it undergoes
Topical GHK-Cu (Copper Tripeptide): Mechanisms & Research Evidence This page summarizes peer-reviewed findings on the topical application of GHK-Cu for skin biologycovering mechanisms (extracellular matrix remodeling, antioxidant/anti-inflammatory activity, and repair signaling), skin permeation data, and clinical/translational studies
Adv Ther 28(3):213226 Frias JP, Nauck MA, Van J, Kutner ME, Cui X, Benson C et al (2018) Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial